Mark Barnett has cut some of former manager Neil Woodford's favourite holdings in the £1.4bn Edinburgh investment trust, adding 14 new stocks since the beginning of the year.
The manager has cut positions in AstraZeneca, BT Group, Capita, GlaxoSmithKline and ReckittBenckiser, and has made new investments in Babcock International, Beazley, BP, Brown (N), CLS, Compass, Derwent...
Industry Voice: Chris Taylor discusses the outlook for Japan, explaining why corporates are producing record aggregate profits and profits growth.
Comes in on 9 December 2019
Latest news and analysis
Primarily smart-beta products
Revealed – successes across all 11 categories